Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Not Confirmed
Not Confirmed
05-06 June, 2025
Not Confirmed
Not Confirmed
05-06 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Industry Trade Show
Not Confirmed
05-06 June, 2025
Industry Trade Show
Not Confirmed
05-06 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
04 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/04/3093497/0/en/Allarity-Therapeutics-Announces-Research-Collaboration-with-Indiana-Biosciences-Research-Institute-to-Further-Advance-Understanding-of-Stenoparib-s-Unique-Dual-Therapeutic-Mechanis.html
02 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/02/3091778/0/en/Allarity-Therapeutics-Announces-First-Patient-Enrolled-in-New-Phase-2-Clinical-Trial-Protocol-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
12 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/12/3079097/0/en/Allarity-Therapeutics-Announces-Participation-in-Pharma-Partnering-Summit-US.html
09 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/09/3078515/0/en/Allarity-Therapeutics-Provides-First-Quarter-2025-Update-Highlighting-Continued-Stenoparib-Benefit-and-Upcoming-Trial-Enrollment.html
25 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/25/3068274/0/en/Allarity-Therapeutics-Presents-Novel-Drug-Response-Predictor-DRP-for-Daratumumab-in-Multiple-Myeloma-at-AACR-2025.html
31 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/31/3052754/0/en/Allarity-Therapeutics-Reports-Full-Year-2024-Financial-Results-and-Provides-a-Business-Update.html
ABOUT THIS PAGE